Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
The Methodist Hospital Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Erasca, Inc.
Ohio State University Comprehensive Cancer Center
Bayer
Pfizer
Boehringer Ingelheim
Phio Pharmaceuticals Inc.
Sandoz
ModernaTX, Inc.
Genentech, Inc.
City of Hope Medical Center
Novartis
Mayo Clinic
Pfizer
M.D. Anderson Cancer Center
AgonOx, Inc.
University of Southern California
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Dana-Farber Cancer Institute
Bayer
Syntrix Biosystems, Inc.
Amgen
University Health Network, Toronto
NeoTX Therapeutics Ltd.
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Seattle Children's Hospital
TScan Therapeutics, Inc.
AstraZeneca
Tesaro, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sichuan Baili Pharmaceutical Co., Ltd.
Microbiotica Ltd
Memorial Sloan Kettering Cancer Center
Asher Biotherapeutics, Inc.
Valo Therapeutics Oy
Formycon AG
TILT Biotherapeutics Ltd.
Toray Industries, Inc
Emory University